Evidence map›Paper›PMID 42437883›Full record

ArticleBMC medical research methodology2026

Adaptive Gaussian process search for simulation-based sample size estimation in clinical prediction models: validation of the pmsims R package.

Oyebayo Ridwan Olaniran, Diana Shamsutdinova, Sarah Markham, Felix Zimmer, Daniel Stahl, Gordon Forbes, Ewan Carr

Abstract readValidation Study
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oyebayo Ridwan OlaniranDepartment of Biostatistics & Health Informatics, King's College London, London, UK. ridwan.olaniran@kcl.ac.uk.
Diana ShamsutdinovaDepartment of Biostatistics & Health Informatics, King's College London, London, UK.
Sarah MarkhamDepartment of Biostatistics & Health Informatics, King's College London, London, UK.
Felix ZimmerIndependent Researcher, Leipzig, Germany.
Daniel StahlDepartment of Biostatistics & Health Informatics, King's College London, London, UK.
Gordon Forbes *Department of Biostatistics & Health Informatics, King's College London, London, UK.
Ewan Carr *Department of Biostatistics & Health Informatics, King's College London, London, UK.

Funding

NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust NIHR203318Research for Patient Benefit Programme NIHR206858
6 · The paper itself

Abstract

backgroundDetermining an adequate sample size is essential for developing reliable and generalisable clinical prediction models, yet practical guidance on selecting appropriate sample size calculation methods remains limited. Existing analytical and simulation-based tools impose restrictive assumptions and focus on mean-based criteria. We present and validate pmsims, an R package that uses Gaussian process (GP) surrogate modelling to provide a flexible and efficient simulation-based framework for sample size determination, validated here across binary, continuous, and survival prediction modelling contexts.

methodsWe conducted a comprehensive simulation study with two aims. Aim 1 compared three search engines implemented in pmsims, a GP surrogate-based adaptive procedure (gp), a deterministic bisection method (bisection), and a hybrid GP-bisection approach (gp-bs), across binary, continuous, and survival outcomes. Scenarios varied outcome prevalence or event rate, predictor dimensionality ([Formula: see text]), target performance metric (discrimination and calibration slope), aggregation criterion (mean vs 80% assurance), and total simulation budget ([Formula: see text]). Each scenario was replicated 100 times; estimator stability was assessed via the coefficient of variation (CV). Aim 2 benchmarked the best-performing pmsims engine against pmsampsize (analytical) and samplesizedev (simulation-based) across a wider range of realistic scenarios, evaluating recommended sample sizes, computational time, and achieved model performance on independent validation datasets of 30,000 observations.

resultsThe GP-based search engine consistently yielded the most stable sample size estimates (lowest CV) across all outcome types, ranking highest in 9/12 outcome-aggregation metric configurations. Its advantage was most pronounced in low-signal, high-dimensional settings, and was accentuated with [Formula: see text] replications per evaluation and a budget of [Formula: see text], after which gains were minimal. In benchmark comparisons, pmsims (mean) achieved performance deviations within [Formula: see text] of the prespecified target across binary, continuous, and survival outcomes, comparable to samplesizedev and substantially outperforming pmsampsize in high-discrimination settings (deviations up to [Formula: see text]).

conclusionsThe pmsims package, using the GP-based search engine with [Formula: see text] replications per evaluation and a budget of [Formula: see text], provides a computationally efficient and flexible framework for principled sample size planning in clinical prediction modelling. It reliably achieves performance targets across the range of standard-model scenarios evaluated while requiring fewer model evaluations than non-adaptive simulation approaches, offering a compelling alternative to both analytical formulae and exhaustive simulation-based search.

Indexed as

Computer SimulationModels, StatisticalSoftwareAlgorithmsHumansNormal DistributionPrediction AlgorithmsReproducibility of ResultsSample SizeAdaptive simulationAssuranceCalibrationDiscriminationGaussian processPrediction modellingR packageSample size planning

Identifiers

PMID42437883
PMCPMC13640277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.